The inhibition of PARP but not EGFR results in the radiosensitization of HPV/p16-positive HNSCC cell lines

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

James A. Bonner, Paul M. Harari, J. Giralt et al. · New England Journal of Medicine · 2006 · 5.1K citations · Full text

Medicine, Oncology, Radiation Oncology +13

Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial

Carole Fakhry, William H. Westra, S. Li et al. · JNCI Journal of the National Cancer Institute · 2008 · 2.8K citations · Full text

Medicine, Radiation Oncology, Chemotherapy +13

Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers

Anil K. Chaturvedi, William F. Anderson, Joannie Lortet‐Tieulent et al. · Journal of Clinical Oncology · 2013 · 1.3K citations · Full text

Medicine, Oncology, Cancer Epidemiology +14

The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair

Claus Storgaard Sørensen, Lasse Tengbjerg Hansen, Jaroslaw Dziegielewski et al. · Nature Cell Biology · 2005 · 648 citations

Life Sciences, Genetics, Molecular Biology +14

Effect of HPV-Associated p16^INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck

P. Lassen, Jesper Grau Eriksen, Stephen Hamilton‐Dutoit et al. · Journal of Clinical Oncology · 2009 · 610 citations

Medicine, Oncology, Radiation Oncology +15